CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $264,622 | -19.1% | 14,227 | -44.2% | 0.08% | -42.1% |
Q3 2022 | $327,000 | +48.0% | 25,480 | -19.3% | 0.13% | +15.7% |
Q2 2022 | $221,000 | -37.0% | 31,571 | -25.4% | 0.12% | -1.7% |
Q1 2022 | $351,000 | -4.9% | 42,293 | -22.6% | 0.12% | +34.5% |
Q4 2021 | $369,000 | +27.7% | 54,618 | 0.0% | 0.09% | +26.1% |
Q3 2021 | $289,000 | -8.0% | 54,618 | 0.0% | 0.07% | +97.1% |
Q2 2021 | $314,000 | – | 54,618 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |